At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 101 enrolled
Drug / intervention
Fentanyl +3 moredrug
Likely dose
Fentanyl 1mcg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy.
In Brief
A Phase 4 clinical trial evaluating Fentanyl and Dexmedetomidine for Tonsillitis. Completed, enrolled 101 participants across 1 site.
Detailed Summary
The primary purpose of this study is: 1. To compare dexmedetomidine with fentanyl in terms of intra-operative hemodynamics and post-operative analgesia. 2. To determine an analgesic dose response relationship for dexmedetomidine. 3. Compare recovery characteristics of dexmedetomidine to fentanyl.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTonsillitis
CountriesUnited States
CollaboratorsHospira, now a wholly owned subsidiary of Pfizer
Timeline
Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2005
First PostedApr 2008
Primary CompletionOct 2008
TodayJul 2026
First PostedApr 8, 2008
Enrollment StartJan 1, 2005
Primary CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 18.2 years ago
Interventions
Fentanyldrug
Fentanyl 1mcg/kg, Intravenous (IV)
Fentanyldrug
Fentanyl 2mcg/kg, Intravenous (IV)
Dexmedetomidinedrug
Dexmedetomidine, 2mcg/kg, Intravenous (IV)
Dexmedetomidinedrug
Dexmedetomidine, 4mcg/kg Intravenous (IV)